The ESMO Advanced Course on ADC Development, Therapeutic Applications and Research in Breast Cancer 2025 will be held on 21–22 November 2025 in Barcelona, Spain.

This course, chaired by Prof. Javier Cortés and Prof. Nadia Harbeck, provides an in-depth exploration of antibody-drug conjugates (ADCs), covering drug development, mechanisms of action, integration into clinical practice, and management of associated toxicities. Accredited with 9 ESMO-MORA category 1 points, it offers participants a comprehensive platform to advance their knowledge and expertise in breast cancer therapeutics.